NIKKEI 225
28,211.36 +35.49 (+0.13%) HANG SENG
20,026.70 -175.24 (-0.87%) CRUDE OIL
88.99 -0.02 (-0.02%) GOLD FUTURES
1,790.80 -0.40 (-0.02%) DOW
32,803.47 +76.67 (+0.23%) BTC-GBP
19,252.01 +152.54 (+0.80%)
SENS Jan 2023 5.000 put
- Zacks
Enovis (ENOV) Q2 Earnings Beat Estimates
Enovis (ENOV) delivered earnings and revenue surprises of 20.41% and 1.39%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- Business Wire
Senseonics Announces a Positive Coverage Decision for Eversense® E3 CGM from Anthem
GERMANTOWN, Md., August 03, 2022--Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that Anthem is providing coverage for implantable CGM, which includes the Eversense® CGM System. Anthem’s decision will add more than 45 million covered lives for the long-term implantable CGM system to help manage their diabetes. T
- Zacks
Syneos Health (SYNH) Beats Q2 Earnings Estimates
Syneos Health (SYNH) delivered earnings and revenue surprises of 4.17% and 1.76%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
